Literature DB >> 20962099

Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses.

Teresa Pollicino1, Giuseppina Raffa, Teresa Santantonio, Giovanni Battista Gaeta, Giuliano Iannello, Angela Alibrandi, Giovanni Squadrito, Irene Cacciola, Chiara Calvi, Giuseppe Colucci, Massimo Levrero, Giovanni Raimondo.   

Abstract

Hepatitis B virus (HBV) and hepatitis delta virus (HDV) interplay was investigated by examining liver and serum samples from 21 coinfected and 22 HBV-monoinfected patients with chronic liver disease. Different real-time PCR assays were applied to evaluate intrahepatic amounts of HBV DNA, covalently closed circular DNA (cccDNA), pregenomic RNA (pgRNA), pre-S/S RNAs, and HDV RNA. Besides HBV DNA and HDV RNA levels, HBsAg concentrations in the sera were also determined. HDV-coinfected cases showed significantly lower median levels of serum HBV DNA (-5 log), intrahepatic relaxed-circular DNA (-2 log), and cccDNA (-2 log) than those of HBV-monoinfected cases. Interestingly, pgRNA and pre-S/S RNA amounts were significantly lower (both -1 log) in HDV-positive patients, whereas serum HBsAg concentrations were comparable between the two patient groups. Pre-S/S RNA and HBsAg amounts per cccDNA molecule were higher in HDV-positive patients (3-fold and 1 log, respectively), showing that HBV replication was reduced, whereas synthesis of envelope proteins was not specifically decreased. The ratios of cccDNA to intracellular total HBV DNA showed a larger proportion of cccDNA molecules in HDV-positive cases. For these patients, both intrahepatic and serum HDV RNA amounts were associated with cccDNA but not with HBsAg or HBV DNA levels. Finally, HBV genomes with large deletions in the basal core promoter/precore region were detected in 5/21 HDV-positive patients but in no HDV-negative patients and were associated with lower viremia levels. These findings provide significant information about the interference exerted by HDV on HBV replication and transcription activities in the human liver.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20962099      PMCID: PMC3014152          DOI: 10.1128/JVI.01609-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  Occult hepatitis B virus infection.

Authors:  Giovanni Raimondo; Teresa Pollicino; Irene Cacciola; Giovanni Squadrito
Journal:  J Hepatol       Date:  2006-11-07       Impact factor: 25.083

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  Virological and clinical characteristics of delta hepatitis in Central Europe.

Authors:  B Heidrich; K Deterding; H L Tillmann; R Raupach; M P Manns; H Wedemeyer
Journal:  J Viral Hepat       Date:  2009-06-28       Impact factor: 3.728

4.  Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D.

Authors:  Melanie Schaper; Francisco Rodriguez-Frias; Rosendo Jardi; David Tabernero; Maria Homs; Gerardo Ruiz; Josep Quer; Rafael Esteban; Maria Buti
Journal:  J Hepatol       Date:  2010-03-05       Impact factor: 25.083

5.  Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.

Authors:  H Sakugawa; H Nakasone; T Nakayoshi; Y Kawakami; T Yamashiro; T Maeshiro; F Kinjo; A Saito; H Zukeran
Journal:  J Med Virol       Date:  2001-11       Impact factor: 2.327

Review 6.  Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis.

Authors:  Mark A Feitelson; Jungmin Lee
Journal:  Cancer Lett       Date:  2006-12-22       Impact factor: 8.679

Review 7.  Hepatitis D: clinical features and therapy.

Authors:  Mario Rizzetto
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

8.  Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction.

Authors:  J C Wu; T Z Chen; Y S Huang; F S Yen; L T Ting; W Y Sheng; S H Tsay; S D Lee
Journal:  Gastroenterology       Date:  1995-03       Impact factor: 22.682

9.  Cloned hepatitis delta virus cDNA is infectious in the chimpanzee.

Authors:  C Sureau; J Taylor; M Chao; J W Eichberg; R E Lanford
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

10.  Hepatitis B Virus e Antigen Variants.

Authors:  Shuping Tong; Kyun-Hwan Kim; Charles Chante; Jack Wands; Jisu Li
Journal:  Int J Med Sci       Date:  2005-01-05       Impact factor: 3.738

View more
  32 in total

1.  Molecular and clinical aspects of hepatitis D virus infections.

Authors:  Elham Shirvani Dastgerdi; Ulf Herbers; Frank Tacke
Journal:  World J Virol       Date:  2012-06-12

2.  Molecular interactions between hepatitis B virus and delta virus.

Authors:  Elham Shirvani-Dastgerdi; Frank Tacke
Journal:  World J Virol       Date:  2015-05-12

3.  Standardized one-step real-time reverse transcription-PCR assay for universal detection and quantification of hepatitis delta virus from clinical samples in the presence of a heterologous internal-control RNA.

Authors:  Caroline Scholtes; Vinca Icard; Majid Amiri; Philippe Chevallier-Queyron; Mary-Anne Trabaud; Christophe Ramière; Fabien Zoulim; Patrice André; Paul Dény
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

4.  Capacity of a natural strain of woodchuck hepatitis virus, WHVNY, to induce acute infection in naive adult woodchucks.

Authors:  Natalia Freitas; Tetyana Lukash; Megan Dudek; Sam Litwin; Stephan Menne; Severin O Gudima
Journal:  Virus Res       Date:  2015-05-12       Impact factor: 3.303

5.  Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers.

Authors:  Natalia Freitas; Tetyana Lukash; Sumedha Gunewardena; Benjamin Chappell; Betty L Slagle; Severin O Gudima
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

Review 6.  Experimental models and therapeutic approaches for HBV.

Authors:  Maura Dandri; Marc Lütgehetmann; Jörg Petersen
Journal:  Semin Immunopathol       Date:  2012-08-17       Impact factor: 9.623

Review 7.  Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.

Authors:  Maura Dandri; Joerg Petersen
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

8.  Treatment options for hepatitis delta virus infection.

Authors:  Benjamin Heidrich; Michael P Manns; Heiner Wedemeyer
Journal:  Curr Infect Dis Rep       Date:  2013-02       Impact factor: 3.725

9.  Epidemiology and molecular characterization of hepatitis B virus infection in isolated villages in the Western Brazilian Amazon.

Authors:  Márcia da Costa Castilho; Cintia Mara Costa de Oliveira; João Bosco de Lima Gimaque; Jorge Di Tommaso Leão; Wornei Silva Miranda Braga
Journal:  Am J Trop Med Hyg       Date:  2012-08-20       Impact factor: 2.345

10.  Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles.

Authors:  Natalia Freitas; Celso Cunha; Stephan Menne; Severin O Gudima
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.